- Editor's PickYahoo Finance•52 minutes ago
Wall Street is in a wait-and-see mode. Stock futures are not making any big moves in either direction as investors remain cautious ahead of Fed Chair Janet Yellen’s speech later this week.
- Editor's PickJulia La Roche•2 days ago
On Monday, Medivation’s (MDVN) stock surged around 20% after pharma giant Pfizer (PFE) said it would acquire the biotech company in a $14 billion deal. Medivation just made its debut on Goldman Sachs’ 50 stocks that “matter most” to hedge funds list, ranking No. 17 on the list. Some hedge funds that opened a new position in Medivation during the second quarter include York Capital Management (5.07 million shares), Tourbillon Capital Partners (4.72 million shares), Pentwater Capital (4.28 million shares), and Eton Park Capital Management (3.08 million shares), 13-F filings show.
- Editor's PickKathy Cherpelis•2 days ago
Medivation (MDVN) stock surged this morning. The cancer drug maker is being bought by Pfizer (PFE) in a deal valued at about $14 billion. The deal is expected to close by the end of the year and will give Pfizer access to Medivation’s cancer drug pipeline.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||35.31 x 100|
|Ask||35.33 x 1000|
|Day's Range||34.91 - 35.27|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||31.11|
|Avg Vol (3m)||22,247,406|
|Dividend & Yield||1.20 (3.44%)|